Pharmacy Times

JUNE 20, 2025

Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease. Kobayashi M, Leidner AJ, Gierke R, et al. MMWR Morb Wkly Rep. 2025;74:1-8. doi:10.15585/mmwr.mm7401a1 3.

Vaccines 29

Vaccines Pharmacy Technician Immunity Immunization 29

Pharmafile

APRIL 1, 2025

Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) taking place 25 to 30 April 2025 in Chicago, Illinois, US. Data will showcase SECN-15s potential to significantly improve the efficacy of immune checkpoint inhibitors (ICIs).

Immunity 59

Immunity Immunization 59

Pharmacy Times

JUNE 24, 2025

Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Pharmacy Times : Can you share an overview of what you discussed at OPC 2025? Author(s): Alexandra Gerlach, Associate Editor , Scott A.

Pharmacy Technician 26

Pharmacy Technician Diabetes Inpatient Compounding Pharmacies 26

Safe Biologics

FEBRUARY 4, 2025

Steqeyma is a human IL-12 and -23 antagonist indicated for multiple immune-mediated diseases, including psoriasis (PsO), psoriatic arthritis (PsA), Crohn’s disease (CD), ulcerative colitis (UC) in adults, and PsO and PsA in pediatric patients 6 years of age and older.

Biosimilars 130

Biosimilars Immunity Immunization 130

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Related Videos Related Content Advertisement June 20th 2025 Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy Kelley D. Sessions : Oncology Pharmacists Connect—this is the third year, right?

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunity 29

BioPharma Dive

JULY 9, 2025

Published July 9, 2025 Gwendolyn Wu Senior reporter post share post print email license Actinium is one of several radioisotopes favored by biotechnology companies developing drugs for cancer. billion in 2025, giving the industry a glimpse of radiopharmaceuticals’ sales potential. The drug earned Novartis more than $1.3

Drug Pricing 62

Drug Pricing Compounding Immunity Immunization 62

Pharmacy Times

JUNE 27, 2025

On January 16, 2025, the FDA approved acalabrutinib (Calquence; AstraZeneca) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT). January 16, 2025. Cancer Treat Rev.

Pharmacy Technician 22

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 22

Express Pharma

JULY 7, 2025

On June 9, 2025, in a significant and controversial shake-up, US Secretary of Health and Human Services Robert F. dismissed all 17 members of the Centers for Disease Control and Prevention (CDC) Advisory Committee for Immunization Practices (ACIP), the body responsible for advising the federal government on vaccine safety. Kennedy Jr.

Vaccines 94

Vaccines Immunity Immunization 94

Pharmacy Times

JULY 12, 2025

At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT). SHOW MORE Pharmacy-based clinical services demonstrate both public health impact and financial sustainability.

Pharmacy Technician 26

Pharmacy Technician Independent Pharmacies Hospitals Compounding Pharmacies 26

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Pharmacy Technician 49

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management 49

Pharmacy Times

JUNE 18, 2025

Wick, MBA, RPh, FASCP Key Takeaways Pharmacists can address SDOH by providing patient-centered care, promoting immunizations, and offering point-of-care testing to improve health outcomes. Offering and promoting immunizations and point-of-care testing are 2 proven ways to address SDOH.

Pharmacy Technician 26

Pharmacy Technician Immunity Immunization Diabetes 26

Pharmacy Times

JUNE 19, 2025

At OPC 2025, Pharmacy Times® spoke with Victoria Nacher, PharmD, BCOP, from Michigan Medicine in Ann Arbor, Michigan, about emerging data and evolutions in the treatment of hematologic malignancies. Pharmacy Times : Can you share an overview of what you discussed at OPC 2025? We talked about the plenary session for [PV].

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunity 26

Pharmacy Times

JUNE 16, 2025

1 The findings were presented at the Revolutionizing Atopic Dermatitis (RAD) 2025 conference held in Nashville, Tennessee. RAD 2025: Long-term data on Nemluvio® (nemolizumab) demonstrate its favorable safety profile and sustained and increased improvements in itch and skin lesions in patients with atopic dermatitis up to two years.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Biosimilars Pharmacy Management 26

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations. Accessed June 9, 2025.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 29

Pharmacy Times

JUNE 25, 2025

Image credit: LASZLO | stock.adobe.com Gabrail et al presented data from a novel strategy involving continuous subcutaneous (SC) infusion of lenalidomide in a poster at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, Illinois.

Pharmacy Technician 20

Pharmacy Technician Immunity Immunization Diabetes 20

Pharmacy Times

JUNE 12, 2025

The findings from this research will be presented at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Pharmacist interventions were accepted both by providers and patients (94%).

Pharmacy Technician 45

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunity 45

Pharmacy Times

JUNE 11, 2025

Related Videos Related Content Advertisement June 11th 2025 Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV Kennedy Ferruggia, Assistant Editor June 3rd 2025 S2.

Pharmacy Technician 26

Pharmacy Technician Hospitals Specialty Pharmacies Compounding Pharmacies 26

Pharmacy Times

JUNE 13, 2025

During the session “Collaborative Practice, Statewide Protocols, and Independent Prescriptive Authority: How Pharmacy is Expanding Services to Increase Access to Patients,” Klepser highlighted the importance of moving beyond product dispensing to provide higher-level services, such as immunizations and medication therapy management.

Pharmacy Technician 35

Pharmacy Technician Immunity Immunization Compounding Pharmacies 35

Pharmacy Times

JUNE 4, 2025

Rockville, MD - June 4, 2025 - The U.S. USP's end-to-end supply chain analytics will help identify risks and opportunities, accelerating technology adoption and regulatory predictability. SHOW MORE Lab will help enable broader adoption of advanced manufacturing technologies and state-of-the-art quality solutions.

Pharmaceutical Manufacturing 26

Pharmaceutical Manufacturing Pharmacy Technician Compounding Pharmacies Compounding 26

Pharmacy Times

JUNE 23, 2025

Accessed May 7, 2025. TOC services are one of many areas where pharmacy models can improve patient outcomes, quality metrics, and hospital revenue. 4-6 Since this study’s completion, the institution has expanded its protocol with additional prescribing opportunities for TOC pharmacists and plans to expand services to non-HRRP patients.

Pharmacy Technician 26

Pharmacy Technician Hospitals Compounding Pharmacies Pharmacy Management 26

Pharmacy Times

JUNE 25, 2025

January 13, 2025. Accessed April 28, 2025. Accessed April 28, 2025. Updated April 10, 2025. Accessed April 28, 2025. Travel Med Infect Dis. 2023;51:102494. doi:10.1016/j.tmaid.2022.102494 2022.102494 2. How to prevent norovirus. Travelers’ health. Measles outbreak case definition.

Pharmacy Technician 20

Pharmacy Technician Medication Therapy Management (MTM) Vaccines Compounding Pharmacies 20

Pharmacy Times

JULY 8, 2025

July 3, 2025. Accessed July 8, 2025. Accessed July 8, 2025. Accessed July 8, 2025. Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial. Doi:10.1182/blood.2024026230 2024026230 2. MInimal Residual Disease Adapted Strategy (MIDAS). Pharmacy Times.

Pharmacy Technician 29

Pharmacy Technician Immunity Immunization Compounding Pharmacies 29

Pharmacy Times

JUNE 20, 2025

1 The supplemental biologics license application was accepted by the FDA for priority review in February 2025. Released June 20, 2025. Accessed June 20, 2025. February 18, 2025. Accessed June 18, 2025. News Release. Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid.

Pharmacy Technician 33

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunity 33

PharmaVoice

JUNE 27, 2025

Published June 27, 2025 Meagan Parrish Lead Editor post share post print email license Justin Sullivan via Getty Images Listen to the article 7 min This audio is auto-generated. pharma is facing potential headwinds as the FDA’s attitude toward immunizations shifts under new leadership. Please let us know if you have feedback.

Vaccines 130

Vaccines Dosage Packaging Immunity 130

Pharmacy Times

JUNE 20, 2025

Pharmacy Times: What are some key sessions that will be presented at the upcoming 2025 ADA Scientific Sessions? Pharmacy Times: How do you anticipate the research from ADA 2025 will influence future updates to the ADA Standards of Care? Isaacs : I am so excited for the ADA Scientific Sessions. It is just so exciting.

Diabetes 32

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management 32

Pharmacy Times

JUNE 30, 2025

Receiving CAR T therapy can take several weeks, and though very effective against difficult-to-treat cancers, it can sometimes cause life-threatening adverse events, such as cytokine release syndrome (CRS) or immune effector cell-associated neurotoxicity syndrome (ICANS). Released June 27, 2025. Accessed June 30, 2025.

Pharmacy Technician 40

Pharmacy Technician Compounding Pharmacies Immunity Immunization 40

Pharmacy Times

JUNE 23, 2025

Soefje, PharmD, MBA, BCOP, during the Hematology/Oncology Pharmacy Association (HOPA) 2025 Annual Conference in Portland, Oregon. Presented at: Hematology/Oncology Pharmacy Association 2025 Annual Conference; April 9-12, 2025; Portland, OR. That’s the system we are headed into very rapidly.” REFERENCE Soefje SA.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Proactive strategies in oncology care enhance financial sustainability and improve patient outcomes.

Mail-Order Pharmacies 29

Mail-Order Pharmacies Pharmacy Technician Compounding Pharmacies Inpatient 29

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share what you presented at the 2025 OPC meeting? Heidi Finnes, PharmD, BCOP, FHOPA : I shared new hope in cutaneous malignancies and abstracts from the 2025 ASCO meeting. Heidi Finnes, PharmD, BCOP, FHOPA : I shared new hope in cutaneous malignancies and abstracts from the 2025 ASCO meeting.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Immunity Immunization 26

Pharmacy Times

JUNE 9, 2025

June 9, 2025. Accessed June 9, 2025. Updated June 3, 2025. Accessed June 9, 2025. Updated June 3, 2025. Accessed June 9, 2025. Efficacy and safety of GMRx2 compared to dual combinations for the treatment of hypertension (GMRx2_ACT).

Pharmacy Technician 33

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunity 33

Pharmacy Times

JULY 2, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician 26

Pharmacy Technician Inpatient Compounding Pharmacies Hospitals 26

Pharmacy Times

JUNE 11, 2025

Image Credit: © Chinnapong - stock.adobe.com At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025, an encore presentation from the Pacific Coast Reproductive Society Annual Meeting will highlight findings from a retrospective analysis conducted by Walgreens Specialty Pharmacy.

Pharmacy Technician 29

Pharmacy Technician Specialty Pharmacies Compounding Pharmacies Biosimilars 29

Pharmacy Times

JULY 12, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician 26

Pharmacy Technician Dosage Compounding Pharmacies Pharmacy Management 26

Pharmaceutical Technology

JUNE 13, 2025

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. The technology utilises outer membrane vesicles (OMVs) to deliver antigens, often eliminating the need for adjuvants while triggering the immune response. Login Registration is disabled.

Vaccines 87

Vaccines Communication Hospitals Packaging 87

Pharmacy Times

JUNE 12, 2025

Because biologics and biosimilar products are large and complex proteins, there is a higher risk of a patient’s body identifying them as an “outside source” and mounting an immune response to them.

Biosimilars 29

Biosimilars Pharmacy Technician Immunity Immunization 29

Pharmacy Times

JULY 4, 2025

Patients with inflammatory conditions achieved similar clinical outcomes after switching from the reference adalimumab (Humira; AbbVie) to a biosimilar, according to real-world data presented at the 2025 American Society of Health-System Pharmacists Pharmacy Futures Meeting. Accessed June 26, 2025. June 12, 2025. June 7–11.

Biosimilars 34

Biosimilars Specialty Pharmacies Pharmacy Technician Hospitals 34

Pharmacy Times

JUNE 27, 2025

Accessed May 13, 2025. Accessed May 13, 2025. Accessed May 13, 2025. REFERENCES 1. Nine things to know about biosimilars and interchangeable biosimilars. Updated June 20, 2024. Biosimilar medicines: overview. European Medicines Agency. April 2015. McClellan JE, Conlon HD, Bolt MW, et al.

Biosimilars 20

Biosimilars Pharmacy Technician Diabetes Compounding Pharmacies 20